Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oragenics Inc
(NY:
OGEN
)
0.3549
-0.0321 (-8.29%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oragenics Inc
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
On Tuesday, 120 companies set new 52-week lows.
Via
Benzinga
Oragenics to Participate in the 2022 BioFlorida Annual Conference
October 24, 2022
From
Oragenics, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 20, 2022
It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news!
Via
InvestorPlace
Oragenics Issues Letter to Shareholders
September 30, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
August 24, 2022
From
Oragenics, Inc.
Via
Business Wire
Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket
August 24, 2022
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities.
Via
Benzinga
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
June 23, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports
June 14, 2022
From
Oragenics, Inc
Via
Business Wire
Oragenics Issues Letter to Shareholders
May 17, 2022
From
Oragenics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Oragenics's Earnings: A Preview
April 26, 2022
Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will...
Via
Benzinga
Oragenics to Participate at the World Vaccine Congress Washington 2022
April 18, 2022
From
Oragenics, Inc.
Via
Business Wire
Earnings Scheduled For April 27, 2022
April 27, 2022
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.
Via
Benzinga
Oragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses
April 06, 2022
From
Oragenics, Inc.
Via
Business Wire
68 Biggest Movers From Yesterday
April 05, 2022
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...
Via
Benzinga
Executives Buy Around $5.5M Of 3 Penny Stocks
April 04, 2022
US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
March 31, 2022
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
March 25, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
March 22, 2022
From
Oragenics, Inc.
Via
Business Wire
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
March 10, 2022
Oragenics Inc (NYSE: OGEN) has entered into an agreement with KBI Biopharma Inc for the process transfer, process optimization, and cGMP manufacturing of...
Via
Benzinga
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
January 26, 2022
From
Oragenics, Inc.
Via
Business Wire
5 Stocks Insiders Are Buying Right Now
January 07, 2022
Several stocks that insiders are buying are worth watching as we enter the new year. This week, that list includes F, CRCT, CHWY and OGEN.
Via
InvestorPlace
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project
January 04, 2022
Nvidia (NVDA) is bringing its metaverse project, titled Omniverse, out of beta and letting creators take advantage of the service.
Via
InvestorPlace
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
January 04, 2022
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the...
Via
Benzinga
OGEN Stock Alert: The Insider Buying Giving Oragenics Shares Some Oomph Today
January 04, 2022
Oragenics (OGEN) stock is rising higher on Tuesday following news of massive insider buying at the development-stage company.
Via
InvestorPlace
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
January 04, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...
Via
Benzinga
Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine
December 20, 2021
Oragenics Inc (NYSE: OGEN) has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) to enable Oragenics to pursue an...
Via
Benzinga
Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant
December 20, 2021
From
Oragenics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.